You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Omicron vaccine

Showing 1 - 25 of 8,312
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

COVID-19, Vaccines Trial in Santiago (CoronaVac®, Omicron Vaccine, Trivalent Vaccine)

Recruiting
  • COVID-19
  • Vaccines
  • CoronaVac®
  • +2 more
  • Santiago, Metropolitana, Chile
  • +2 more
Jan 12, 2023

COVID-19 Trial in Wong Chuk Hang (COVID-19 Vaccine (Vero Cell), Inactivated, Omicron Strain)

Recruiting
  • COVID-19
  • COVID-19 Vaccine (Vero Cell), Inactivated, Omicron Strain
  • Wong Chuk Hang, HongKong, China
    Gleneagles Hospital HongKong
Jul 4, 2022

Coronavirus Trial (Omicron BA.4/5-Delta strain recombinant novel coronavirus protein vaccine (CHO cells), Recombinant novel

Not yet recruiting
  • Coronavirus
  • Omicron BA.4/5-Delta strain recombinant novel coronavirus protein vaccine (CHO cells)
  • Recombinant novel coronavirus protein vaccine (CHO cells)
  • (no location specified)
Sep 5, 2023

Coronavirus Trial in Wuhu (Omicron BA.4/5-Delta strain recombinant novel coronavirus protein vaccine (CHO cells), Recombinant

Active, not recruiting
  • Coronavirus
  • Omicron BA.4/5-Delta strain recombinant novel coronavirus protein vaccine (CHO cells)
  • Recombinant novel coronavirus protein vaccine (CHO cells)
  • Wuhu, Anhui, China
    Wannan Medical College Yijishan Hospital
May 6, 2023

COVID-19 Trial (Omicron BA.4/5-Delta strain recombinant novel coronavirus protein vaccine (CHO cells), Placebo)

Not yet recruiting
  • COVID-19
  • Omicron BA.4/5-Delta strain recombinant novel coronavirus protein vaccine (CHO cells)
  • Placebo
  • (no location specified)
Sep 22, 2023

COVID-19, Influenza, Vaccine Reaction Trial in Seoul, Incheon (Omicron-containing COVID-19 vaccine, influenza vaccine)

Recruiting
  • COVID-19
  • +3 more
  • Omicron-containing COVID-19 vaccine
  • influenza vaccine
  • Seoul, Guro-gu, Korea, Republic of
  • +1 more
Oct 17, 2023

SARS-CoV-2 Trial (SARS-CoV-2 Variant (Omicron BA.5) mRNA Vaccine low dose, SARS-CoV-2 Variant (Omicron BA.5) mRNA Vaccine high

Not yet recruiting
  • SARS-CoV-2
  • SARS-CoV-2 Variant (Omicron BA.5) mRNA Vaccine low dose
  • +2 more
  • (no location specified)
Dec 1, 2022

SARS-CoV-2 Trial in Bengbu (SARS-CoV-2 Variant (Omicron BA.5) mRNA vaccine Low dose, SARS-CoV-2 Variant (Omicron BA.5) mRNA

Active, not recruiting
  • SARS-CoV-2
  • SARS-CoV-2 Variant (Omicron BA.5) mRNA vaccine Low dose
  • +2 more
  • Bengbu, Anhui, China
    First Affiliated Hospital Bengbu Medical College
Jan 3, 2023

SARS-CoV-2 Trial in Bengbu (SARS-CoV-2 Variant (Omicron BA.5) mRNA vaccine, Saline solution)

Recruiting
  • SARS-CoV-2
  • SARS-CoV-2 Variant (Omicron BA.5) mRNA vaccine
  • Saline solution
  • Bengbu, Anhui, China
    First Affiliated Hospital Bengbu Medical College
Feb 26, 2023

COVID-19 Trial in Huai'an (COVID-19 Vaccine (Vero cell), Inactivated (Omicron variant), COVID-19 Vaccine (Vero cell),

Recruiting
  • COVID-19
  • COVID-19 Vaccine (Vero cell), Inactivated (Omicron variant)
  • COVID-19 Vaccine (Vero cell), Inactivated (CZ strain)
  • Huai'an, Jiangsu, China
    Huaiyin Center for Disease Control and Prevention
Jan 11, 2023

Vaccine Reaction, COVID-19 Trial in Paris (Comirnaty® BNT162b2 /Omicron BA.4-5 vaccine (Pfizer-BioNTech), VidPrevtyn® Beta

Not yet recruiting
  • Vaccine Reaction
  • COVID-19
  • Comirnaty® BNT162b2 /Omicron BA.4-5 vaccine (Pfizer-BioNTech)
  • VidPrevtyn® Beta vaccine (Sanofi/GSK)
  • Paris, France
    CIC 1417 Cochin-Pasteur
Feb 28, 2023

COVID-19 Trial (NVX-CoV2601 co-formulated Omicron XBB.1.5 SARS-CoV-2 rS vaccine, Prototype/XBB.1.5 Bivalent Vaccine (5 µg))

Not yet recruiting
  • COVID-19
  • NVX-CoV2601 co-formulated Omicron XBB.1.5 SARS-CoV-2 rS vaccine
  • Prototype/XBB.1.5 Bivalent Vaccine (5 µg)
  • (no location specified)
Aug 4, 2023

COVID-19 Trial in Bengbu (Recombinant Omicron-Delta COVID-19 Vaccine (CHO Cell), Inactivated COVID-19 vaccine (Vero Cell))

Active, not recruiting
  • COVID-19
  • Recombinant Omicron-Delta COVID-19 Vaccine (CHO Cell)
  • Inactivated COVID-19 vaccine (Vero Cell)
  • Bengbu, Anhui, China
    The First Affiliated Hospital of Bengbu Medical College
Nov 3, 2022

COVID-19 Pandemic, Immunogenicity, SARS CoV 2 Infection Trial in Ramat-Gan (mRNA-1273.214 Vaccine, MRNA-1273 Vaccine, Placebo)

Recruiting
  • COVID-19 Pandemic
  • +3 more
  • mRNA-1273.214 Vaccine
  • +2 more
  • Ramat-Gan, Israel
    Sheba Medical Center
Oct 26, 2022

COVID-19 Trial (Bivalent BNT162b2 (original/Omicron BA.4/BA.5) 3 microgram dose, Bivalent BNT162b2 (original/Omicron BA.4/BA.5)

Not yet recruiting
  • COVID-19
  • Bivalent BNT162b2 (original/Omicron BA.4/BA.5) 3 microgram dose
  • +3 more
  • (no location specified)
Dec 22, 2022

COVID-19 Trial in Tashkent (Omicron-Delta Recombinant Novel Coronavirus Protein Vaccine (CHO cells), Recombinant Novel

Recruiting
  • COVID-19
  • Omicron-Delta Recombinant Novel Coronavirus Protein Vaccine (CHO cells)
  • Recombinant Novel Coronavirus Protein Vaccine (CHO cells)
  • Tashkent, Uzbekistan
    Uzbekistan, Tashkent city, Said baraka street 10
Nov 11, 2022

COVID-19 Trial in Hong Kong (BIBP Omicron Inactivated COVID-19 vaccine (Vero Cell), WIBP Omicron Inactivated COVID-19 vaccine

Recruiting
  • COVID-19
  • BIBP Omicron Inactivated COVID-19 vaccine (Vero Cell)
  • +2 more
  • Hong Kong, Hong Kong
    Queen Mary Hospital
May 27, 2022

COVID-19 Trial in Paris (Lymph node aspiration / Blood sampling)

Recruiting
  • COVID-19
  • Lymph node aspiration / Blood sampling
  • Paris, France
    GH Broca-Cochin-Hôtel-Dieu CIC 1417 Cochin-Pasteur
Jul 19, 2023

Immune Response, Safety Trial in Incheon (bivalent BNT162b2 mRNA original/omicron BA.4-5 vaccine, quadrivalent influenza

Active, not recruiting
  • Immune Response
  • Safety
  • bivalent BNT162b2 mRNA original/omicron BA.4-5 vaccine
  • quadrivalent influenza vaccine
  • Incheon, Seo-gu, Korea, Republic of
    International St. Mary's hospital
Jul 28, 2023

SARS-CoV-2 Virus, Severe Acute Respiratory Syndrome Coronavirus 2, COVID-19 Trial (Bivalent BNT162b2 (original/Omicron

Not yet recruiting
  • SARS-CoV-2 Virus
  • +2 more
  • Bivalent BNT162b2 (original/Omicron BA.4/BA.5) 3 microgram dose
  • +4 more
  • (no location specified)
Sep 14, 2022

Moderna COVID-19 Bivalent Booster for Omicron BA.4/5

Recruiting
  • COVID-19
  • Moderna COVID-19 Vaccine
  • +3 more
  • Culver City, California
    Science37
Mar 9, 2023

COVID-19 Vaccine Trial in Argentina (Gamma Variant RBD-based ARVAC-CG vaccine, Omicron Variant RBD-based ARVAC-CG vaccine,

Recruiting
  • COVID-19 Vaccine
  • Gamma Variant RBD-based ARVAC-CG vaccine
  • +3 more
  • Argentina, C.a.b.a., Argentina
    Centro de Educación Médica e Investigaciones Clínicas "Norberto
Feb 28, 2023

HIV, Organ Transplantation, Lymphoma, Non-Hodgkin Trial in Melbourne (Pfizer Bivalent COVID-19 Vaccine, Moderna Bivalent mRNA

Recruiting
  • HIV
  • +5 more
  • Pfizer Bivalent COVID-19 Vaccine
  • Moderna Bivalent mRNA vaccine
  • Melbourne, Victoria, Australia
    Alfred Health
Jan 31, 2023

COVID-19 Trial in Changde, Changning, Zhuzhou (Omicron COVID-19 Vaccine (Vero Cell), Inactivated, COVID-19 Vaccine (Vero Cell),

Recruiting
  • COVID-19
  • Omicron COVID-19 Vaccine (Vero Cell), Inactivated
  • COVID-19 Vaccine (Vero Cell), Inactivated
  • Changde, Hunan, China
  • +2 more
May 30, 2022

COVID-19 Trial in Hangzhou (Omicron COVID-19 Vaccine (Vero Cell), Inactivated)

Recruiting
  • COVID-19
  • Omicron COVID-19 Vaccine (Vero Cell), Inactivated
  • Hangzhou, Zhejiang, China
    Shulan (hangzhou) Hospital
May 5, 2022